PathologybioRxiv
EPAC1 Inhibition Protects the Heart from Doxorubicin-Induced Toxicity
M. Mazevet, A. Belhadef, M. Ribeiro…·E. Morel
This study shows that inhibiting EPAC1 protects the heart from doxorubicin-induced toxicity without affecting its cancer-killing effects.
DOI 10.7554/elife.83831